Eugene D. Kwon
Mayo Clinic · 362 works · 20,579 citations · h-index 69
Top works
- Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up
- Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
- Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.
- 618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target
- Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
- Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy
- Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
- Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma
- Clinical significance of defective dendritic cell differentiation in cancer.
- PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma
- PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata
- Urachal carcinoma: Clinicopathologic features and long‐term outcomes of an aggressive malignancy
- Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
- Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma
- Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
- T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival
- B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
- Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
- Tumor B7-H1 and B7-H3 Expression in Squamous Cell Carcinoma of the Lung
- T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer